Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
John Z Metcalfe, MD, PhD
Abstract
TS ELiOT is a stepped-wedge, cluster randomized trial assessing the effect of a next-generation sequencing-based strategy on rifampin-resistant tuberculosis management and patient outcomes.
MeSH terms
- Tuberculosis, Multidrug-Resistant
- HIV Infections